H.C. Wainwright & Co., LLC, announced its #1 Ranking by transaction volume for the calendar year of 2024, maintaining the Firm’s top position for 11 consecutive years in PlacementTracker's Market ...
H.C. Wainwright has recently reduced Cassava Sciences Inc (SAVA) stock to Neutral rating, as announced on November 26, 2024, according to Finviz. Earlier, on October 8, 2024, H.C. Wainwright had ...
H.C. Wainwright increased its price target for Akero Therapeutics (NASDAQ:AKRO) shares, setting a new goal of $72.00, up from the previous target of $50.00. The firm maintained its Buy rating on the ...
H.C. Wainwright raised the firm’s price target on Akero Therapeutics (AKRO) to $72 from $50 and keeps a Buy rating on the shares after the ...
Humacyte Inc (HUMA) stock saw a modest uptick, ending the day at $4.61 which represents a slight increase of $0.02 or 0.44% from the prior close of $4.59. The stock opened at $4.59 and touched a low ...
In a report released today, Emily Bodnar from H.C. Wainwright maintained a Hold rating on Agenus (AGEN – Research Report). The company’s shares ...
In conclusion, H.C. Wainwright's analyst remains optimistic about Immunocore's prospects, underpinned by the potential of its diverse pipeline and upcoming clinical milestones. With a market ...
LSI Industries (NASDAQ:LYTS – Free Report) had its target price raised by Canaccord Genuity Group from $22.00 to $26.00 in a research note published on Friday,Benzinga reports. The brokerage currently ...
Guggenheim reissued their buy rating on shares of Dyne Therapeutics (NASDAQ:DYN – Free Report) in a report released on Friday,Benzinga reports. Other equities analysts have also recently issued ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback